CORC

在结果中检索

CORC

浏览/检索结果: 共273条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
收藏  |  浏览/下载：14/0  |  提交时间：2023/11/10
Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
收藏  |  浏览/下载：19/0  |  提交时间：2022/12/23
Exploratory hrd and PD-L1 analysis of l-MOCA study: Olaparib maintenance monotherapy in Asian patients with platinum-sensitive relapsed ovarian cancer. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Ma, Ding;  Gao, Qing-Lei;  Zhu, Jianqing;  Zhao, Weidong;  Huang, Yi
收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23
The Prognostic Utility of F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Li, Cong;  Yu, Haifeng;  Chen, Xi;  Han, Shuiyun;  Peng, Shuailing
收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022
作者:  Liu, Jihong;  Yin, Rutie;  Wu, Lingying;  Zhu, Jianqing;  Lou, Ge
收藏  |  浏览/下载：31/0  |  提交时间：2022/05/05
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma 期刊论文
BLOOD ADVANCES, 2022, 卷号: 6
作者:  Yang, Haiyan;  Xiang, Bing;  Song, Yuqin;  Zhang, Huilai;  Zhao, Weili
收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：29/0  |  提交时间：2022/05/05
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao
收藏  |  浏览/下载：43/0  |  提交时间：2022/02/14
Tislelizumab Plus GemOx in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Single-Arm, Multi-Center Phase II Trial 期刊论文
BLOOD, 2021, 卷号: 138
作者:  Ding, Kaiyang;  Liu, Hailing;  Yang, Haiyan;  Cao, Lei;  Zhao, Xiaoli
收藏  |  浏览/下载：9/0  |  提交时间：2022/12/23
The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma 期刊论文
BLOOD, 2021, 卷号: 138
作者:  Ding, Kaiyang;  Shi, Xiao;  Yang, Haiyan;  Cao, Lei;  Zhao, Xiaoli
收藏  |  浏览/下载：8/0  |  提交时间：2022/12/23

©版权所有 ©2017 CSpace - Powered by CSpace